EUVIMEDEUVIMED entdecken
Crossref

L26/P-421 Potential of microRNA therapy to preserve growing mice follicles during the chemotherapy exposure

C. Pavoncelli, G. Van Den Steen, J. Dechène, G. Bruylants, I. Demeestere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. Pavoncelli und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does let-7a microRNA transfection mitigate the damage induced by cyclophosphamide metabolite (4-HC) to cultured growing follicles? Summary answer Although chemotherapy reduces let-7a expression, our results suggested that let7-a mimic transfection during 4-HC exposure fails to prevent chemotherapy-induced damage to growing ovarian follicles. What is known already Let-7, a miRNA involved in apoptosis and survival pathways, has previously been shown to be downregulated by chemotherapy in post-natal-day-3 mouse ovaries. In the same model, restoring Let-7 levels through lipofectamine-based transfection, protected the quiescent follicular pool, preventing 4-HC-induced apoptosis damage in vitro. Study design, size, duration Preantral follicles were mechanically isolated from prepubertal mice (aged 12 to 14 days) ovaries which predominantly contain secondary follicles. Each follicle was individually cultured in microdroplets for 4 days and exposed to treatments before prolonging culture either 30 hours or 7 days to evaluate respectively the short-term and long-term effect. The half of medium was refreshed every 2 days until day 10 of culture and medium was stored at -80 °C for further hormonal analysis. Participants/materials, setting, methods From day 4, preantral follicles were treated with (1) a single or a repeated dose (at day 4-6-8-10) of 10 µM or 20 µM of 4-HC (2) a single dose of lipofectamine-mediated let-7a mimic (3pmol or 10pmol) (3) a single dose of let-7a mimic (3pmol) with or without 4-HC. The survival, morphology, estradiol level and let-7a expression profile of follicle were assessed at long-term for 4-HC and lipofectamine-mediated let-7a mimic, alone or in cotreatment. Main results and the role of chance 4-HC exposure induced a dose-dependent damage on growing follicles reducing both mean survival rate (20μM at day 4-6-8-10; 52.43% ± 18.26 p < 0.001, 10μM at day 4-6-8-10; 68.85% ± 8.77 p < 0.01, 20μM at day 4; 62.42% ± 11.72 p < 0.001, 10μM at day 4; 64.85% ± 5.43 p < 0;001) and normal morphology rate (20μM at day 4-6-8-10; 0% ± 0, 10μM at day 4-6-8-10; 3.17% ± 3.7, 20μM at day 4; 0.43% ± 1.05, p < 0.001) compared with negative control condition at day 10 (91.07% ± 7.95 and 80.18% ± 16.05, respectively). The 4-HC exposure, whether a single or repeated dose, reduced let-7a expression by day 11 in growing follicles: 20μM at day 4-6-8-10 p = 0.021, 10μM at day 4-6-8-10 p = 0.05, 20μM at day 4 p = 0.042 compared with negative control condition. After 30 hours of 4-HC/20µM exposure, let-7a tended to be downregulated (p = 0.087) with an upregulated effect on stat3, one of its target genes (p = 0.044). The let-7a transfection proved effective and non-toxic. However, preliminary data did not demonstrate a beneficial effect of cotreatment with 3pmol let-7a mimic transfection during 4-HC/10µM exposure. Additional experiments are ongoing including let-7a mimic transfection during 4-HC/20µM exposure as well as hormonal assay. Limitations, reasons for caution The study is limited to let-7a microRNA while other miRNAs were affected by chemotherapy. Expanding the potential of miRNA as well as miRNAs coupling will be considered. Wider implications of the findings Models assessing chemotherapy-induced ovarian damage in growing and quiescent follicles are complementary, as effects appear to differ by follicular stage. Although these preliminary results are negative, microRNA-based therapy remains an interesting approach for future research on follicular gonadotoxicity and for developing non-invasive pharmacological strategies for ovarian protection. Trial registration number No

Zitieren

APA

Pavoncelli, C., Steen, G. V. D., Dechène, J., Bruylants, G., & Demeestere, I. (2026). L26/P-421 Potential of microRNA therapy to preserve growing mice follicles during the chemotherapy exposure. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.755

Vancouver

Pavoncelli C, Steen GVD, Dechène J, Bruylants G, Demeestere I. L26/P-421 Potential of microRNA therapy to preserve growing mice follicles during the chemotherapy exposure. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.755

BibTeX
@article{Pavoncelli2026,
  author = {Pavoncelli, C. and Steen, G. Van Den and Dechène, J. and Bruylants, G. and Demeestere, I.},
  title = {L26/P-421 Potential of microRNA therapy to preserve growing mice follicles during the chemotherapy exposure},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.755}
}
Kostenlos starten →